These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 1642394)

  • 1. The current management and prognosis of acral lentiginous melanoma.
    Wells KE; Reintgen DS; Cruse CW
    Ann Plast Surg; 1992 Jan; 28(1):100-3. PubMed ID: 1642394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin-Like Growth Factor II mRNA-Binding Protein 3 Expression Correlates with Poor Prognosis in Acral Lentiginous Melanoma.
    Sheen YS; Liao YH; Lin MH; Chiu HC; Jee SH; Liau JY; Chang YL; Chu CY
    PLoS One; 2016; 11(1):e0147431. PubMed ID: 26796627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Significance of Subungual Anatomic Site in Acral Lentiginous Melanoma.
    Mejbel HA; Torres-Cabala CA; Milton DR; Ivan D; Nagarajan P; Curry JL; Ciurea AM; Rubin AI; Hwu WJ; Prieto VG; Aung PP
    Arch Pathol Lab Med; 2021 Aug; 145(8):943-952. PubMed ID: 33290520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acral lentiginous melanoma.
    Ridgeway CA; Hieken TJ; Ronan SG; Kim DK; Das Gupta TK
    Arch Surg; 1995 Jan; 130(1):88-92. PubMed ID: 7802583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unique prognostic factors in acral lentiginous melanoma.
    Egger ME; McMasters KM; Callender GG; Quillo AR; Martin RC; Stromberg AJ; Scoggins CR
    Am J Surg; 2012 Dec; 204(6):874-9; discussion 879-80. PubMed ID: 23022254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is the prognosis and course of acral melanoma related to site-specific clinicopathological features?
    Paolino G; Bekkenk MW; Didona D; Eibenschutz L; Richetta AG; Cantisani C; Viti G; Carbone A; Buccini P; De Simone P; Ferrari A; Scali E; Calvieri S; Silipo V; Cigna E; Viti GP; Bottoni U
    Eur Rev Med Pharmacol Sci; 2016 Mar; 20(5):842-8. PubMed ID: 27010139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment and outcomes of melanoma in acral location in Korean patients.
    Roh MR; Kim J; Chung KY
    Yonsei Med J; 2010 Jul; 51(4):562-8. PubMed ID: 20499423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acral Lentiginous Melanoma: A United States Multi-Center Substage Survival Analysis.
    Kolla AM; Vitiello GA; Friedman EB; Sun J; Potdar A; Daou H; Farrow NE; Farley CR; Vetto JT; Han D; Tariq M; Beasley GM; Contreras CM; Lowe M; Zager JS; Osman I; Berman RS; Liebman TN; Stein JA; Lee AY
    Cancer Control; 2021; 28():10732748211053567. PubMed ID: 34752172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acral lentiginous melanoma: who benefits from sentinel lymph node biopsy?
    Ito T; Wada M; Nagae K; Nakano-Nakamura M; Nakahara T; Hagihara A; Furue M; Uchi H
    J Am Acad Dermatol; 2015 Jan; 72(1):71-7. PubMed ID: 25455840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age as a prognostic factor in the malignant melanoma population.
    Austin PF; Cruse CW; Lyman G; Schroer K; Glass F; Reintgen DS
    Ann Surg Oncol; 1994 Nov; 1(6):487-94. PubMed ID: 7850555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrent malignant melanoma: the identification of prognostic factors to predict survival.
    Reintgen DS; Cox C; Slingluff CL; Seigler HF
    Ann Plast Surg; 1992 Jan; 28(1):45-9. PubMed ID: 1642405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathologic analysis of malignant melanoma in Taiwan.
    Chen YJ; Wu CY; Chen JT; Shen JL; Chen CC; Wang HC
    J Am Acad Dermatol; 1999 Dec; 41(6):945-9. PubMed ID: 10570378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological behavior and natural course of acral malignant melanoma. Clinical and histologic features and prognosis of palmoplantar, subungual, and other acral malignant melanomas.
    Jimbow K; Takahashi H; Miura S; Ikeda S; Kukita A
    Am J Dermatopathol; 1984; 6 Suppl():43-53. PubMed ID: 6528942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depth of invasion analysis to predict acral melanoma outcomes.
    Asato MA; Moares-Neto FA; de Toledo Moraes MP; Ocanha-Xavier JP; Takita LC; Marques MEA; Xavier-Júnior JCC
    Ann Diagn Pathol; 2024 Aug; 71():152305. PubMed ID: 38640808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic variables in patients with thick melanomas. Analysis of 362 cases.
    Aguilar-Romero E; Chávez-Hernández JD; Zepeda-Najar C; Salcedo-Hernández RA; Lino-Silva LS
    Gac Med Mex; 2021; 157(2):207-211. PubMed ID: 34270542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acral lentiginous melanoma: Clinicopathologic and survival differences according to tumour location.
    Howard M; Xie C; Wee E; Wolfe R; McLean C; Kelly JW; Pan Y
    Australas J Dermatol; 2020 Nov; 61(4):312-317. PubMed ID: 32363586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of high molecular weight melanoma-associated antigen expression in primary acral lentiginous melanoma lesions with poor prognosis.
    Kageshita T; Kuriya N; Ono T; Horikoshi T; Takahashi M; Wong GY; Ferrone S
    Cancer Res; 1993 Jun; 53(12):2830-3. PubMed ID: 8504426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acral melanoma: a review of 185 patients with identification of prognostic variables.
    Slingluff CL; Vollmer R; Seigler HF
    J Surg Oncol; 1990 Oct; 45(2):91-8. PubMed ID: 2214797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary cutaneous melanoma. Prognostic classification of anatomic location.
    Garbe C; Büttner P; Bertz J; Burg G; d'Hoedt B; Drepper H; Guggenmoos-Holzmann I; Lechner W; Lippold A; Orfanos CE
    Cancer; 1995 May; 75(10):2492-8. PubMed ID: 7736393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinctive dermatoscopic features of acral lentiginous melanoma in situ from plantar melanocytic nevi and their histopathologic correlation.
    Kawabata Y; Tamaki K
    J Cutan Med Surg; 1998 Apr; 2(4):199-204. PubMed ID: 9558302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.